Compugen (CGEN) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Compugen (CGEN) Reports In-Line Q3 EPS

Compugen Reports Third Quarter 2019 Results

November 11, 2019 7:00 AM EST

HOLON, Israel, Nov. 11, 2019 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy  company and a leader in predictive target discovery, today reported financial results for the third quarter ended September 30, 2019.

"Our first presentation of clinical data last week at SITC 2019 is an important milestone for Compugen," said Anat Cohen-Dayag, Ph.D., President and CEO of Compugen. "We are encouraged by the initial signals of anti-tumor activity seen with COM701, a first-in-class PVRIG inhibitor, in... More